Condition
Myeloid Sarcoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Myeloid Sarcoma clinical trials that are recruiting, at sites in 2 countries (most in United States (2), China (2)). By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Myeloid Sarcoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| VAM (liposomal mitoxantrone) for secondary AML and myeloid sarcoma | Phase 2 | Shanghai | Recruiting | Jun 19, 2025 |
| Intensive conditioning for myeloid cancers with extramedullary involvement | — | Shanghai, Shanghai Municipality | Recruiting | Nov 1, 2023 |
| Investigating Ziftomenib with Other Treatments for Acute Myeloid Leukemia | Phase 1 | Phoenix, Arizona and 43 other locations | Recruiting | Feb 21, 2023 |
| Using dexrazoxane to protect the heart during chemotherapy for blood cancers | Phase 2 | Houston, Texas | Recruiting | Jul 18, 2018 |
All recruiting trials (4)
-
VAM (liposomal mitoxantrone) for secondary AML and myeloid sarcoma
This trial will test whether VAM (a liposomal form of mitoxantrone) is effective and safe for adults with secondary AML, therapy-related AML, AML with extramedullary disease, or myeloid sarcoma.
-
Intensive conditioning for myeloid cancers with extramedullary involvement
This study is testing a new treatment plan using specific medications before a stem cell transplant to see if it helps people with myeloid cancers that have spread beyond the bone marrow feel better and have better outcomes.
-
Investigating Ziftomenib with Other Treatments for Acute Myeloid Leukemia
This study is testing if a new drug called ziftomenib, when combined with other treatments, can help people with acute myeloid leukemia who have certain genetic mutations feel better and stay safe during treatment.
-
Using dexrazoxane to protect the heart during chemotherapy for blood cancers
This study is testing if a drug called dexrazoxane can help protect the hearts of people with blood cancers from damage caused by chemotherapy.
Related topics
Quick answers
How many Myeloid Sarcoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.